about
High early mortality in patients with chronic acquired immunodeficiency syndrome diarrhea initiating antiretroviral therapy in Haiti: a case-control studyClinical impact and cost of monitoring for asymptomatic laboratory abnormalities among patients receiving antiretroviral therapy in a resource-poor setting.Functional CYP2B6 variants and virologic response to an efavirenz-containing regimen in Port-au-Prince, Haiti.Cost-effectiveness of early versus standard antiretroviral therapy in HIV-infected adults in HaitiHigh mortality among patients with AIDS who received a diagnosis of tuberculosis in the first 3 months of antiretroviral therapy.Superior outcomes and lower outpatient costs with scale-up of antiretroviral therapy at the GHESKIO clinic in Port-au-Prince, Haiti.Partner-Focused Adherence Intervention for Second-line Antiretroviral Therapy: A Multinational Randomized Trial (ACTG A5234).The feasibility, demand, and effect of integrating primary care services with HIV voluntary counseling and testing: evaluation of a 15-year experience in Haiti, 1985-2000.A Second Look at the Association between Gender and Mortality on Antiretroviral TherapyTrends in CD4 Count Testing, Retention in Pre-ART Care, and ART Initiation Rates over the First Decade of Expansion of HIV Services in Haiti.Diagnosis of HIV-Associated Oral Lesions in Relation to Early versus Delayed Antiretroviral Therapy: Results from the CIPRA HT001 TrialVirologic, clinical and immunologic responses following failure of first-line antiretroviral therapy in HaitiThe cost of antiretroviral therapy in Haiti.A successful model for rapid triage of symptomatic patients at an HIV testing site in HaitiBinge drinking is associated with differences in weekday and weekend adherence in HIV-infected individuals.Early versus standard antiretroviral therapy for HIV-infected adults in Haiti.5-year survival of patients with AIDS receiving antiretroviral therapy in HaitiClinical and genetic determinants of plasma nevirapine exposure following an intrapartum dose to prevent mother-to-child HIV transmissionAttrition from HIV testing to antiretroviral therapy initiation among patients newly diagnosed with HIV in Haiti.Survival, plasma HIV-1 RNA concentrations and drug resistance in HIV-1-infected Haitian adolescents and young adults on antiretroviralsCholera vaccination in urban Haiti.Lives saved by expanding HIV treatment availability in resource-limited settings: the example of Haiti.Factors impacting the provision of antiretroviral therapy to people living with HIV: the view from Haiti.Live with the Disease Like You Used to Before You Knew You Were Infected: A Qualitative Study Among 10-Year Survivors Living with HIV in Haiti.Antiretroviral therapy in a thousand patients with AIDS in Haiti.Same-day HIV testing with initiation of antiretroviral therapy versus standard care for persons living with HIV: A randomized unblinded trial.Preliminary investigation of human exhaled breath for tuberculosis diagnosis by multidimensional gas chromatography - Time of flight mass spectrometry and machine learning.Blood pressure and mortality in a prospective cohort of HIV-infected adults in Port-au-Prince, Haiti.Partner-based adherence intervention for second-line antiretroviral therapy (ACTG A5234): a multinational randomised trialMultidrug-resistant tuberculosis at an HIV testing center in HaitiOne Month of Rifapentine plus Isoniazid to Prevent HIV-Related Tuberculosis
P50
Q30414385-FFE8C29E-287B-4784-8A47-9661C6D3F763Q33390898-706FFE03-26D6-40D0-9847-3A08D9510795Q33909980-25FBCE00-3886-4AF9-ACD5-BF5AD9138C25Q34031173-DB5B21E9-7276-47DD-8D70-5B1B0F38BCC5Q34444002-E9B9ABA9-9D90-4025-BA96-1A875520107AQ34775595-95804200-14C4-4548-831F-1B89C6CCB800Q35037738-6B7884CF-39D2-4EF8-81B1-03562C99FCB0Q35180426-965EDEA5-2C27-4738-A6CC-B1261FCB6880Q35839742-36A04F2E-E767-4399-BE31-109AE67F860DQ35931409-90A6BEC4-4F80-4D23-8BAD-D48F50971CF7Q35941275-DC38C48E-3494-4E56-8A74-8B61CFB5DAF5Q36404121-A225E426-56E0-4D46-909B-381977A5F043Q36512486-8A479378-ABCE-49F5-B7CC-BCA7F055F9A8Q36754725-BF4A759F-52D3-42B3-980D-269DE6493BB6Q36882901-FDD9E57A-484C-427C-917E-7D010E2E77E3Q36914021-46C78BA7-FD79-4DD3-8E92-B454EA920280Q36914062-B48EBFAB-370B-4D15-A107-8337C257A2E0Q37037070-C51725D3-3960-4B4B-841F-228BDF7577C9Q37086356-603F2E77-382C-4D8C-8906-690B3FB83C4BQ37113268-01B0270C-C3FD-474A-B2DC-6938B7B108F4Q37225765-36896086-C544-495E-AAEB-4A6EC12B3766Q37290659-07D3443B-2381-4F84-BDA2-93C6B72ECB77Q38259619-8E83FE6B-EC3C-41BB-84A4-E95BA7C9B1FEQ38914960-1C9E66DD-38A3-40DC-8B32-70E612C3B19DQ39447948-FD1FA7A8-988D-46C3-9045-A7B77CFA90F8Q40120400-16C34E3F-FDC1-410D-B05C-A9519D736873Q47657442-4C8D0A58-2076-4D6D-8FA0-4CCC12A949BFQ52596500-79050415-0AC9-4C68-B964-43E1BB894004Q56915651-A3D52052-F250-4AF1-A208-0D8460B7E4B4Q58076451-D11F40F0-E307-4604-BA2A-9D3F7057514DQ62486259-6EA36428-97BB-43ED-9CC0-1C71C5B8A3C4
P50
name
Patrice Severe
@en
type
label
Patrice Severe
@en
prefLabel
Patrice Severe
@en